Related donor marrow transplant for chronic myeloid leukemia: Patient characteristics predictive of outcome

Bone Marrow Transplantation

Volumn 17, Issue 4, 1996, Pages 537-542

  Enright, H ^a,b   Daniels, K ^a   Arthur, D C ^a   Dusenbery, K E ^a   Kersey, J H ^a   Kim, T ^a   Miller, W J ^a   Ramsay, N K C ^a   Vercellotti, G M ^a   Weisdorf, D J ^a   McGlave, P B ^a  

^a University of Minnesota   (United States)

^b UNIV OF MINNESOTA HOSP AND CLINIC   (United States)

Author keywords

Allogeneic marrow transplant; Bone marrow transplant; Chronic myeloid leukemia

Indexed keywords

HEMOGLOBIN; METHOTREXATE; PREDNISONE; THYMOCYTE ANTIBODY;

ADOLESCENT; ADULT; ADVANCED CANCER; AGE; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; BONE MARROW TRANSPLANTATION; CANCER MORTALITY; CANCER RECURRENCE; CHILD; CHROMOSOME ANALYSIS; CHRONIC MYELOID LEUKEMIA; FEMALE; HUMAN; HUMAN CELL; INFANT; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; MYELOFIBROSIS; ONSET AGE; PRESCHOOL CHILD; PRIORITY JOURNAL; QUALITY OF LIFE; RISK FACTOR; SCHOOL CHILD; SPLENOMEGALY; SURVIVAL; THROMBOCYTE COUNT; TREATMENT OUTCOME;

ADOLESCENT; ADULT; BONE MARROW TRANSPLANTATION; CAUSE OF DEATH; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; GRAFT VS HOST DISEASE; HISTOCOMPATIBILITY; HUMANS; INFANT; LEUKEMIA, MYELOID, PHILADELPHIA-POSITIVE; LIFE TABLES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYELOFIBROSIS; NUCLEAR FAMILY; PARENTS; PROGNOSIS; QUALITY OF LIFE; RISK; SPLENECTOMY; SPLENOMEGALY; SURVIVAL ANALYSIS; TISSUE DONORS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 0029670056     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Thomas ED, Clift RA, Fefer A et al. Marrow transplantation for the treatment of chronic myelogenous leukemia. Ann Intern Med 1986; 104. 155-163.
2. Goldman JM, Apperley JF, Jones L et al. Bone marrow transplantation for patients with chronic myeloid leukemia. New Engl J Med 1986; 314: 202-207.
3. Clift RA, Buckner CD, Appelbaum FR et al. Allogeneic bone marrow transplantation in patients with chronic myeloid leukemia in chronic phase: a randomized trial of two irradiation regimens. Blood 1991; 77: 1660-1665.
4. McGlave PB. Therapy of chronic myelogenous leukemia with bone marrow transplantation. In: Champlin R (ed). Bone Marrow Transplantation. Kluwer Academic: Boston, MA, 1990, pp 235-258.
5. Speck B, Bortin MM, Champlin RE et al. Allogeneic bone marrow transplantation for chronic myelogenous leukemia. Lancet 1984; 1: 665-668.
6. Clift RA, Buckner CD, Thomas ED et al. Marrow transplantation for patients in accelerated phase of chronic myeloid leukemia. Blood 1994; 84: 4368-4373.
7. Champlin RE, Goldman RM, Gale RP. Bone marrow transplantation in chronic myelogenous leukemia. Semin Hematol 1988; 25: 74-80.
8. Thomas ED, Clift RA. Indications for marrow transplantation in chronic myelogenous leukemia. Blood 1989; 73: 861-864.
9. Martin PJ, Clift RA, Fisher LD et al. HLA-identical marrow transplantation during accelerated-phase chronic myelogenous leukemia: analysis of survival and remission duration. Blood 1988; 72: 1978-1984.
10. Kantarjian HM, Smith TL, McCredie KB et al. Chronic myelogenous leukemia: a multivariate analysis of the associations of patient characteristics and therapy with survival. Blood 1985; 66: 1326-1335.
11. Sokal JE, Baccarani M, Tura S et al. Prognostic discrimination among younger patients with chronic granulocytic leukemia: relevance to bone marrow transplantation. Blood 1985; 66: 1352-1357.
12. Kantarjian HM, Deisseroth A, Kurzrock R et al. Chronic myelogenous leukemia: a concise update. Blood 1993; 82: 691-703.
13. Ramsay NK, Kersey JH, Robison LL et al. A randomized study of the prevention of acute graft-versus-host disease. New Engl J Med 1982; 306: 392-397.
14. Filipovich AH, Krawczek CL, Kersey JH et al. Graft-versus-host disease prophylaxis with anti-T-cell monoclonal antibody OKT3, prednisone and methotrexate in allogeneic bone marrow transplantation. Br J Haematol 1985; 60: 143-152.
15. McGlave PB, Bartsch G, Anasetti C et al. Unrelated donor marrow transplantation therapy for chronic myelogenous leu-kemia: initial experience of the National Marrow Donor program. Blood 1993; 81: 543-550.
16. Mantel N. Evaluation of survival data and two new rank order statistics arising in its considerations. Cancer Chemother Rep 1966; 50: 163-170.
17. Cox DR. Regression models and life tables (with discussion). J R Stat Soc 1972; 34: 187-201.
18. Kaplan E, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
19. McGlave PB. Therapy of chronic myelogenous leukemia with related or unrelated bone marrow transplantation. Leukemia 1992; 6: 115-117.
20. Cullis JO, Marks DI, Schwarer AP et al. Relapse into blast crisis following bone marrow transplantation for chronic myeloid leukemia. A report of 5 cases. Br J Haematol 1982; 81: 378-382.
21. Ely P, Miller W. BCR/ABL mRNA detection following bone marrow transplantation for chronic myelogenous leukemia. Transplantation 1991; 52: 1023-1028.
22. Hughes TP, Morgan GJ, Martial P, Goldman JM. Detection of residual leukemia after bone marrow transplant for chronic myeloid leukemia. Role of polymerase chain reaction in predicting relapse. Blood 1991; 77: 874-878.
23. Roth MS, Antin JH, Ash R et al. Prognostic significance of Philadelphia chromosome-positive cells detected by the polymerase chain reaction after allogeneic bone marrow transplant for chronic myelogenous leukemia. Blood 1992: 79: 276-282.
24. Przepiorka D, Thomas ED. Prognostic significance of cytogeneric abnormalities in patients with chronic myelogenous leukemia. Bone Marrow Transplant 1988; 3: 113-119.